ALICANCT06467175
The Benefits of Long-read High-throughput Genomic Sequencing for the Causal Diagnosis of Cerebellar Ataxias
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved at least 1 year 5 months later.
See at-risk trials from Centre Hospitalier Universitaire Dijon
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Jun 2028 to Dec 2029
- Eligibility criteria expanded, about 10 words
- Primary endpoints: details revised at 1 of 1 entry
- Notable Primary and study completion dates: Mar 2027 to Jun 2028v3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Sep 2024 to Dec 11, 2024
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Identification of a causal genetic variant (class 4 or 5 variant - ACMG classification) that may explain the patients' symptoms.
Timeframe: Through study completion, on average of 18 months
Arms and interventions
cax index with 1 to 2 relativesExperimental
Biologicals: blood sampling for high molecular weight DNA extraction
Sites
1 site in 1 country
- Chu Dijon BourgogneDijon, France